Log In
Print
BCIQ
Print
Print this Print this
 

rozrolimupab (Sym001)

  Manage Alerts
Collapse Summary General Information
Company Symphogen A/S
DescriptionA mixture of 25 human mAbs against rhesus D (RhD)
Molecular Target Rhesus D (RhD)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today